Bradford D. Dahms, Theravance's Chief Financial Officer, recently acquired 1,971 shares of the company. The buys took place at $10.15 per share, on December 21, 2021. Dahms now owns 1,970 shares of the company. Dahms operates out of Cambridge, MA. Some additional info was provided as follows:
The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transaction at prices ranging from $10.09 to $10.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
The above information was dis closed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Theravance makes a similar move, sign up!